Targeting pancreatic cancer to improve treatment options
Selective Targeting of Pancreatic Cancer SPORE
This study is looking into pancreatic cancer to find out what causes it and how to create better treatments, so that patients can receive more personalized care based on their unique situation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10911125 on NIH RePORTER |
What this research studies
This research focuses on pancreatic cancer, a highly lethal disease with limited treatment options. It aims to understand the complex genetic and environmental factors contributing to the disease and to develop targeted therapies. The approach includes genomic analyses and preclinical efforts to identify biomarkers that can help tailor treatments for patients. By addressing challenges such as low tumor cellularity and chemotherapy resistance, the research seeks to enhance precision oncology for pancreatic cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer, particularly those with advanced disease or limited treatment options.
Not a fit: Patients with early-stage pancreatic cancer or those who do not have a confirmed diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promise in developing targeted therapies for pancreatic cancer, but this approach aims to address unique challenges that have not been fully explored.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Yeh, Jen Jen — Univ of North Carolina Chapel Hill
- Study coordinator: Yeh, Jen Jen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.